genOway Société anonyme Statistics

Total Valuation

genOway Société anonyme has a market cap or net worth of EUR 34.51 million. The enterprise value is 36.03 million.

Market Cap	34.51M
Enterprise Value	36.03M

Important Dates

The next estimated earnings date is Tuesday, December 24, 2024.

Earnings Date	Dec 24, 2024
Ex-Dividend Date	n/a

Share Statistics

genOway Société anonyme has 9.01 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	9.01M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	10.38%
Owned by Institutions (%)	n/a
Float	6.07M

Valuation Ratios

The trailing PE ratio is 27.48.

PE Ratio	27.48
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	2.84
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	28.68
EV / Sales	1.28
EV / EBITDA	6.50
EV / EBIT	28.57
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.99, with a Debt / Equity ratio of 0.36.

Current Ratio	1.99
Quick Ratio	1.83
Debt / Equity	0.36
Debt / EBITDA	1.15
Debt / FCF	n/a
Interest Coverage	8.09

Financial Efficiency

Return on equity (ROE) is 7.20% and return on invested capital (ROIC) is 3.19%.

Return on Equity (ROE)	7.20%
Return on Assets (ROA)	2.45%
Return on Capital (ROIC)	3.19%
Revenue Per Employee	219,392
Profits Per Employee	9,812
Employee Count	133
Asset Turnover	0.87
Inventory Turnover	10.44

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -15.27% in the last 52 weeks. The beta is 0.51, so genOway Société anonyme's price volatility has been lower than the market average.

Beta (5Y)	0.51
52-Week Price Change	-15.27%
50-Day Moving Average	3.71
200-Day Moving Average	3.97
Relative Strength Index (RSI)	49.91
Average Volume (20 Days)	5,881

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, genOway Société anonyme had revenue of EUR 28.08 million and earned 1.26 million in profits.

Revenue	28.08M
Gross Profit	15.72M
Operating Income	1.26M
Pretax Income	1.21M
Net Income	1.26M
EBITDA	5.54M
EBIT	1.26M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 4.86 million in cash and 6.38 million in debt, giving a net cash position of -1.51 million or -0.17 per share.

Cash & Cash Equivalents	4.86M
Total Debt	6.38M
Net Cash	-1.51M
Net Cash Per Share	-0.17
Equity (Book Value)	17.78M
Book Value Per Share	n/a
Working Capital	8.58M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 55.99%, with operating and profit margins of 4.49% and 4.47%.

Gross Margin	55.99%
Operating Margin	4.49%
Pretax Margin	4.32%
Profit Margin	4.47%
EBITDA Margin	19.74%
EBIT Margin	4.49%
FCF Margin	n/a

Dividends & Yields

genOway Société anonyme does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

genOway Société anonyme has an Altman Z-Score of 2.97. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.97
Piotroski F-Score	n/a